David C. Guth, Jr., CEO of Centerstone, has issued a statement on the Federal Communications Commission’s report on the National Suicide Hotline Improvement Act of 2018: “We applaud the Federal Communications Commission for their work over the last year in exploring the feasibility and need for a national three-digit phone line to be designated ...
Dozens of bills produced by the House of Representatives recently became Centerstone’s top priorities. Among them, the Opioid Prevention and Patient Safety Act (OPPS Act) (H.R.5795) is the most controversial and hotly contested among lawmakers and stakeholders. These bills and the Protecting Jessica Grubb’s Legacy Act (S 1012) in the Senate – ensure that medical ...
Following a rough-and-tumble start to the 116th Congress, policies that could positively impact Centerstone are once again being introduced. Congress passed sweeping opioid legislation entitled the SUPPORT for Patients and Communities Act last year, but omitted a couple of our priorities from the final law. Background Recently, the U.S. House and U.S. Senate both reintroduced ...
The Indiana State Senate Committee on Health & Provider Services recently held a hearing on Senate Bill 33 to establish certification and a grant program for comprehensive addiction recovery centers to be administered by the division of mental health and addiction (division). ...
We are witnessing the first reduction in life expectancy for young American adults since the 1960s as a result of overdoses and suicides. This chilling trend has left a lasting impact on our families, communities, and economy. According to a 2017 National Safety Council survey, 70% of employers reported their business had been affected by ...
We applaud both the House of Representatives and the Senate for drafting and passing the SUPPORT for Patients and Communities Act, designed to curb a growing national opioid crisis, which claimed more than 70,000 American lives last year. As a front-lines provider of evidence-based behavioral health services, we at Centerstone see the vast opportunities this ...
The U.S. Senate is now scheduled to vote on the Opioid Crisis Response Act of 2018 on Monday, September 17. Upon anticipated passage, leaders in the House and Senate are expected to quickly reconcile differences between the two chambers’ bills. While the existing legislation represents critical steps in addressing the opioid and drug epidemic that ...
Last month, Centerstone’s Legislative Advocacy team shared the anticipated timeline of a Senate vote on their version of an opioid package, noting it could come anywhere between July and December, 2018. They are now hearing that the Senate could vote on their version of an opioid package starting sometime next week. The team wants to offer ...
We applaud the U.S. House of Representatives for their critical work in passing the Opioid Prevention and Patient Safety Act (OPPS Act). This legislation will allow health care providers to practice truly integrated care – a key factor in our nation’s fight against the opioid epidemic. The OPPS Act will update an antiquated regulation – ...
On Wednesday, June 20, the Opioid Prevention and Patient Safety Act (OPPS Act) (H.R.6082) will go to the House floor for a full House vote. Centerstone has encouraged you to reach out to your representatives to make your support for the OPPS Act known and today, the final push is on. This is your last chance to ...
